CASTELLONE, MARIA DOMENICA
CASTELLONE, MARIA DOMENICA
Istituto di Endocrinologia e Oncologia Sperimentale ''G. Salvatore'' - IEOS
Serine 897 Phosphorylation of EPHA2 Is Involved in Signaling of Oncogenic ERK1/2 Drivers in Thyroid Cancer Cells
2020 Allocca, Chiara; Cirafici, ANNA MARIA; Laukkanen Mikko, O; Castellone, MARIA DOMENICA
Antitumor Efficacy of Dual Blockade of EGFR Signaling by Osimertinib in Combination With Selumetinib or Cetuximab in Activated EGFR Human NCLC Tumor Models
2018 Della Corte C.M.; Ciaramella V.; Cardone C.; La Monica S.; Alfieri R.; Petronini P.G.; Malapelle U.; Vigliar E.; Pepe F.; Troncone G.; Castellone M.D.; Troiani T.; Martinelli E.; Ciardiello F.; Morgillo F.
Combined inhibition of MEK and PI3KCA pathway induces synergic antitumor activity in HER2 amplified human colorectal cancer models
2018 Belli, V.; Matrone, N.; Napolitano, S.; Martinelli, E.; Castellone, M. D.; Trusolino, L.; Giunta, E. F.; De Falco, V.; Zanaletti, N.; Vitiello, P. P.; Ciardiello, D.; Terminiello, M.; Ciardiello, F.; Troiani, T.
Reduced expression of ?-L-Fucosidase-1 (FUCA-1) predicts recurrence and shorter cancer specific survival in luminal B LN+ breast cancer patients.
2018 Bonin S; Parascandolo A; Aversa C; Barbazza R; Tsuchida N; Castellone MD; Stanta G; Vecchio G;.
RET-mediated modulation of tumor microenvironment and immune response in multiple endocrine neoplasia type 2 (MEN2).
2018 Castellone, Md; Melillo, Rm
Extracellular Superoxide Dismutase Expression in Papillary Thyroid Cancer Mesenchymal Stem/Stromal Cells Modulates Cancer Cell Growth and Migration
2017 Parascandolo, A; Rappa, F; Cappello, F; Kim, J; Cantu, Da; Chen, H; Mazzoccoli, G; Hematti, P; Castellone, Md; Salvatore, M; Laukkanen, Mo
Human ?-L-fucosidase-1 attenuates the invasive properties of thyroid cancer
2017 Vecchio, G; Parascandolo, A; Allocca, C; Ugolini, C; Basolo, F; Moracci, M; Strazzulli, A; Cobucciponzano, B; Laukkanen, Mo; Castellone, Md; Tsuchida, N
TGF-beta1, WNT, and SHH signaling in tumor progression and in fibrotic diseases.
2017 Castellone, Maria D; Laukkanen, Mikko O
A loss-of-function genetic screening identifies novel mediators of thyroid cancer cell viability.
2016 Cantisani, Mc; Parascandolo, A; Perälä, M; Allocca, C; Fey, V; Sahlberg, N; Merolla, F; Basolo, F; Laukkanen, Mo; Kallioniemi, Op; Santoro, M; Castellone, Md
Hijacking the hedgehog pathway in cancer therapy
2016 Laukkanen, Mo; Castellone, Md
Metformin increases antitumor activity of MEK inhibitors through GLI1 downregulation in LKB1 positive human NSCLC cancer cells
2016 Della Corte C.M.; Ciaramella V.; Di Mauro C.; Castellone M.D.; Papaccio F.; Fasano M.; Sasso F.C.; Martinelli E.; Troiani T.; De Vita F.; Orditura M.; Bianco R.; Ciardiello F.; Morgillo F.
Cross talk between the bombesin neuropeptide receptor and Sonic hedgehog pathways in small cell lung carcinoma
2015 Castellone M.D.; Laukkanen M.O.; Teramoto H.; Bellelli R.; Ali G.; Fontanini G.; Santoro M.; Gutkind J.S.
Extracellular Superoxide Dismutase Regulates the Expression of Small GTPase Regulatory Proteins GEFs, GAPs, and GDI
2015 O Laukkanen, Mikko; Cammarota, Francesca; Esposito, Tiziana; Salvatore, Marco; Castellone, MARIA DOMENICA
Gastrin-Releasing Peptide Receptor Targeting in Cancer Treatment: Emerging Signaling Networks and Therapeutic Applications.
2015 Laukkanen MO; Castellone MD.
Sonic Hedgehog in SCLC
2015 Laukkanen, Mo; Gutkind, Js; Castellone, Md
Extracellular Superoxide Dismutase Induces Mouse Embryonic Fibroblast Proliferative Burst, Growth Arrest, Immortalization, and Consequent In Vivo Tumorigenesis.
2014 Castellone MD; Langella A; Cantara S; Laurila JP; Laatikainen LE; Bellelli R; Pacini F; Salvatore M; Laukkanen MO.
CD44 proteolysis increases CREB phosphorylation and sustains proliferation of thyroid cancer cells.
2012 De Falco V; Tamburrino A; Ventre S; Castellone MD; Malek M; Manié SN; Santoro M.
FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinoma.
2012 Bellelli, R; Castellone, Md; Garciarostan, G; Ugolini, C; Nucera, C; Sadow, Pm; Nappi, Tc; Salerno, P; Cantisani, Mc; Basolo, F; Gago, Ta; Salvatore, G; Santoro, M
Biomarkers in thyroid tumor research: New diagnostic tools and potential targets of molecular-based therapy
2011 Gimm, Oliver; Castellone, MARIA DOMENICA; Hoangvu, Cuong; Kebebew Electron, K
SOD3 Decreases Ischemic Injury Derived Apoptosis through Phosphorylation of Erk1/2, Akt, and FoxO3a.
2011 Laatikainen, LE ; Incoronato, M ; Castellone, MD ; Laurila, JP ; Santoro, M ; Laukkanen, MO ,
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Serine 897 Phosphorylation of EPHA2 Is Involved in Signaling of Oncogenic ERK1/2 Drivers in Thyroid Cancer Cells | 1-gen-2020 | Allocca, Chiara; Cirafici, ANNA MARIA; Laukkanen Mikko, O; Castellone, MARIA DOMENICA | |
| Antitumor Efficacy of Dual Blockade of EGFR Signaling by Osimertinib in Combination With Selumetinib or Cetuximab in Activated EGFR Human NCLC Tumor Models | 1-gen-2018 | Della Corte C.M.; Ciaramella V.; Cardone C.; La Monica S.; Alfieri R.; Petronini P.G.; Malapelle U.; Vigliar E.; Pepe F.; Troncone G.; Castellone M.D.; Troiani T.; Martinelli E.; Ciardiello F.; Morgillo F. | |
| Combined inhibition of MEK and PI3KCA pathway induces synergic antitumor activity in HER2 amplified human colorectal cancer models | 1-gen-2018 | Belli, V.; Matrone, N.; Napolitano, S.; Martinelli, E.; Castellone, M. D.; Trusolino, L.; Giunta, E. F.; De Falco, V.; Zanaletti, N.; Vitiello, P. P.; Ciardiello, D.; Terminiello, M.; Ciardiello, F.; Troiani, T. | |
| Reduced expression of ?-L-Fucosidase-1 (FUCA-1) predicts recurrence and shorter cancer specific survival in luminal B LN+ breast cancer patients. | 1-gen-2018 | Bonin S; Parascandolo A; Aversa C; Barbazza R; Tsuchida N; Castellone MD; Stanta G; Vecchio G;. | |
| RET-mediated modulation of tumor microenvironment and immune response in multiple endocrine neoplasia type 2 (MEN2). | 1-gen-2018 | Castellone, Md; Melillo, Rm | |
| Extracellular Superoxide Dismutase Expression in Papillary Thyroid Cancer Mesenchymal Stem/Stromal Cells Modulates Cancer Cell Growth and Migration | 1-gen-2017 | Parascandolo, A; Rappa, F; Cappello, F; Kim, J; Cantu, Da; Chen, H; Mazzoccoli, G; Hematti, P; Castellone, Md; Salvatore, M; Laukkanen, Mo | |
| Human ?-L-fucosidase-1 attenuates the invasive properties of thyroid cancer | 1-gen-2017 | Vecchio, G; Parascandolo, A; Allocca, C; Ugolini, C; Basolo, F; Moracci, M; Strazzulli, A; Cobucciponzano, B; Laukkanen, Mo; Castellone, Md; Tsuchida, N | |
| TGF-beta1, WNT, and SHH signaling in tumor progression and in fibrotic diseases. | 1-gen-2017 | Castellone, Maria D; Laukkanen, Mikko O | |
| A loss-of-function genetic screening identifies novel mediators of thyroid cancer cell viability. | 1-gen-2016 | Cantisani, Mc; Parascandolo, A; Perälä, M; Allocca, C; Fey, V; Sahlberg, N; Merolla, F; Basolo, F; Laukkanen, Mo; Kallioniemi, Op; Santoro, M; Castellone, Md | |
| Hijacking the hedgehog pathway in cancer therapy | 1-gen-2016 | Laukkanen, Mo; Castellone, Md | |
| Metformin increases antitumor activity of MEK inhibitors through GLI1 downregulation in LKB1 positive human NSCLC cancer cells | 1-gen-2016 | Della Corte C.M.; Ciaramella V.; Di Mauro C.; Castellone M.D.; Papaccio F.; Fasano M.; Sasso F.C.; Martinelli E.; Troiani T.; De Vita F.; Orditura M.; Bianco R.; Ciardiello F.; Morgillo F. | |
| Cross talk between the bombesin neuropeptide receptor and Sonic hedgehog pathways in small cell lung carcinoma | 1-gen-2015 | Castellone M.D.; Laukkanen M.O.; Teramoto H.; Bellelli R.; Ali G.; Fontanini G.; Santoro M.; Gutkind J.S. | |
| Extracellular Superoxide Dismutase Regulates the Expression of Small GTPase Regulatory Proteins GEFs, GAPs, and GDI | 1-gen-2015 | O Laukkanen, Mikko; Cammarota, Francesca; Esposito, Tiziana; Salvatore, Marco; Castellone, MARIA DOMENICA | |
| Gastrin-Releasing Peptide Receptor Targeting in Cancer Treatment: Emerging Signaling Networks and Therapeutic Applications. | 1-gen-2015 | Laukkanen MO; Castellone MD. | |
| Sonic Hedgehog in SCLC | 1-gen-2015 | Laukkanen, Mo; Gutkind, Js; Castellone, Md | |
| Extracellular Superoxide Dismutase Induces Mouse Embryonic Fibroblast Proliferative Burst, Growth Arrest, Immortalization, and Consequent In Vivo Tumorigenesis. | 1-gen-2014 | Castellone MD; Langella A; Cantara S; Laurila JP; Laatikainen LE; Bellelli R; Pacini F; Salvatore M; Laukkanen MO. | |
| CD44 proteolysis increases CREB phosphorylation and sustains proliferation of thyroid cancer cells. | 1-gen-2012 | De Falco V; Tamburrino A; Ventre S; Castellone MD; Malek M; Manié SN; Santoro M. | |
| FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinoma. | 1-gen-2012 | Bellelli, R; Castellone, Md; Garciarostan, G; Ugolini, C; Nucera, C; Sadow, Pm; Nappi, Tc; Salerno, P; Cantisani, Mc; Basolo, F; Gago, Ta; Salvatore, G; Santoro, M | |
| Biomarkers in thyroid tumor research: New diagnostic tools and potential targets of molecular-based therapy | 1-gen-2011 | Gimm, Oliver; Castellone, MARIA DOMENICA; Hoangvu, Cuong; Kebebew Electron, K | |
| SOD3 Decreases Ischemic Injury Derived Apoptosis through Phosphorylation of Erk1/2, Akt, and FoxO3a. | 1-gen-2011 | Laatikainen, LE ; Incoronato, M ; Castellone, MD ; Laurila, JP ; Santoro, M ; Laukkanen, MO , |